Skip to main content

Silk Road Medical Inc

SILKDelisted Sep 17, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001397702

Silk Road Medical Inc was delisted on Sep 17, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 172 institutions reported holding it in 13F filings for Q2 2024, worth $1.03B in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
172
Q2 2024, +19 vs. previous quarter
13F value
$1.03B
Reported value at the end of Q2 2024
Superinvestors holding
0
At the end of Q2 2024

Superinvestors holding SILK, Q2 2024

Go to the superinvestors tab

No superinvestor reported holding SILK at the end of Q2 2024.

Latest insider trades

Open-market purchases and sales by Silk Road Medical Inc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 21, 2024 (view filing)Aug 192 daysKlemz Kevin MEVP/Chief Legal Officer/Sec.SSale−2.27K$27.10−$61.5K−1.4%162.9K after
Jul 8, 2024 (view filing)Jul 35 daysDavis Andrew S.Chief Commercial OfficerSSale−66$27.00−$1.78K0.0%289.7K after
Mar 7, 2024 (view filing)Mar 52 daysBallinger Kevin J.DirectorPPurchase+11.7K$16.99+$198.8K+191.6%17.8K after
Mar 5, 2024 (view filing)Mar 5Same dayBuchanan Lucas W.COO/CFOSSale−9.88K$17.17−$169.6K−1.9%500.9K after
Mar 5, 2024 (view filing)Mar 5Same dayRuedy RichardEVPClin&Reg.Affairs&QASSale−3.80K$17.17−$65.2K−1.8%205.7K after
Mar 5, 2024 (view filing)Mar 5Same dayDavis Andrew S.Chief Commercial OfficerSSale−5.48K$17.17−$94.1K−1.9%287.8K after
Mar 5, 2024 (view filing)Mar 5Same dayJones Marie L.VP, Finance and CAOSSale−2.60K$17.17−$44.7K−3.3%76.9K after
Mar 5, 2024 (view filing)Mar 5Same dayKlemz Kevin MEVP/Chief Legal Officer/Sec.SSale−2.50K$17.17−$42.9K−1.5%165.2K after
Mar 4, 2024 (view filing)Feb 294 daysRuedy RichardEVPClin&Reg.Affairs&QASSale−3.00K$22.25−$66.8K−1.7%170.8K after10b5-1
Oct 30, 2023 (view filing)Oct 273 daysJones Marie L.CAO and VP, FinanceSSale−656$6.61−$4.34K−1.2%54.9K after

Top 10 13F holders, Q2 2024

The largest institutional positions in Silk Road Medical Inc at the end of Q2 2024; share changes are against Q1 2024.

See all 172 holders
Institutions holding SILK in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock Inc.3,367,732$91.1M0.00%+394,775+13.3%Added
Vanguard Group Inc2,970,143$80.3M0.00%+47,648+1.6%Added
Magnetar Financial LLC1,970,373$53.3M1.11%+1,970,373New
FIL Ltd1,577,754$42.7M0.04%+1,577,754New
Bamco Inc1,279,115$34.6M0.10%−221,055−14.7%Reduced
D. E. Shaw & Co., Inc.1,154,781$31.2M0.04%−444,710−27.8%Reduced
TimesSquare Capital Management, LLC1,098,739$29.7M0.47%+426,605+63.5%Added
State Street Corp1,072,041$29.0M0.00%+33,774+3.3%Added
Capital World Investors969,500$26.2M0.00%−2,142,230−68.8%Reduced
Nuveen Asset Management, LLC926,327$25.0M0.01%+530,091+133.8%Added

Congress trades

1 member of Congress reported 1 trade in Silk Road Medical Inc since 2020. Newest filings:

All congress trades in SILK
  1. Daniel S. Goldman

    Democrat · House · NY · Apr 17, 2023

    Sell$1K-$15K